Hemispherx Biopharma Inc (HEB.A)

HEB.A on American Stock Exchange

0.27USD
22 Jul 2014
Price Change (% chg)

$0.01 (+3.05%)
Prev Close
$0.26
Open
$0.27
Day's High
$0.29
Day's Low
$0.27
Volume
355,721
Avg. Vol
130,269
52-wk High
$0.55
52-wk Low
$0.19

HEB.A

Chart for HEB.A

About

Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Hemispherx focuses on two core pharmaceutical technology platforms Ampligen... (more)

Overall

Beta: 1.08
Market Cap (Mil.): $50.19
Shares Outstanding (Mil.): 183.85
Dividend: --
Yield (%): --

Financials

  HEB.A Industry Sector
P/E (TTM): -- 102.18 35.85
EPS (TTM): -0.10 -- --
ROI: -44.67 -0.10 18.25
ROE: -44.84 -0.88 19.12
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF80.20 -0.35
Pfizer Inc. (PFE.N) $30.49 +0.14
Merck & Co., Inc. (MRK.N) $58.48 +0.05
GlaxoSmithKline plc (GSK.L) 1,456.95p -98.50
AstraZeneca plc (AZN.L) 4,413.50p -12.50
Baxter International Inc. (BAX.N) $77.21 +0.34
MediGene AG (MDG1k.DE) €5.05 -0.05

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks